Rare diseases
Investigational molecules
Locations
Back to France3 345 clinical trials in St Germain En Laye, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies
FranceStudy of Pembrolizumab with Etoposide and Cisplatin for First-Line Treatment in Patients with Small Cell Ovarian Cancer
FranceStudy on Early Oxybutynin Treatment for Boys with Posterior Urethral Valves
FranceEvaluation of drug combination therapy (olaparib, nilotinib, tremelimumab, and durvalumab) for patients with advanced or metastatic solid tumors
FranceStudy on Atezolizumab, Amivantamab, and Futibatinib for Patients with Advanced Solid Tumors
FranceStudy on the Effect of Recombinant Human Interferon Gamma 1b for Patients with Post-Aggressive Immunosuppression in Intensive Care
FranceStudy of rituximab and mycophenolate mofetil combination therapy compared to placebo for patients with interstitial lung disease related to systemic sclerosis
FranceStudy of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer
FranceStudy on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases
FranceStudy of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceStudy on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli
FranceStudy on Colchicine for Reducing Heart Damage in Patients with Acute Myocarditis
FranceThe busiest research cities in the country
What the registry says about research in the country
Investigating innovative combination therapies for follicular lymphoma, comparing mosunetuzumab plus lenalidomide against standard treatments to improve progression-free survival in previously untreated patients.
Research focuses on enhancing treatment outcomes for high-risk lymphoma patients.
Evaluating treatment strategies for elderly women with HER2-negative breast cancer, examining the effectiveness of combined chemotherapy and hormone therapy based on genomic profiling.
Studies aim to optimize treatment outcomes for senior patients while considering their specific needs.
Investigating treatment optimization for Secondary Progressive Multiple Sclerosis patients, focusing on the safety and efficacy of disease-modifying therapy withdrawal in stable patients over 50.
Research aims to enhance quality of life while maintaining disease stability.
Examining preventive strategies for pregnancy-associated hypertension and pre-eclampsia through controlled trials of acetylsalicylic acid treatment in pregnant women with chronic hypertension.
Focus on reducing maternal and fetal morbidity through preventive care.
Investigating the effects of preoperative cholecalciferol supplementation on post-thyroidectomy outcomes, specifically focusing on preventing hypocalcemia complications.
Research aims to improve patient recovery and reduce hospital stays after thyroid surgery.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
